🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT03402919
Recruiting Observational

Comprehensive Assessment of Neurodegeneration and Dementia

NCT03402919 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2016-06
Last updated
2026-01-20

Condition(s) studied

DementiaMild Cognitive Impairment (MCI)Subjective Cognitive ImpairmentParkinson's Disease (PD)Lewy Body Disease(LBD)Mixed DementiaFrontotemporal Dementia (FTD)Alzheimer Disease (AD)Cognitively UnimpairedSubjective Cognitive Decline (SCD)

Study summary

This is a longitudinal observational study recruiting individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group without cognitive deficits. Participants are/will be recruited at sites across Canada and will undergo assessments, neuroimaging, and biological sample collection.

Eligibility

Sex
ALL
Min age
50 Years
Max age
90 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Has subjective or objective cognitive impairment * Written informed consent must be obtained and documented (from the patient or, where jurisdictions allow it, from a caregiver/family member) * Sufficient proficiency in English or French to undertake self report and neuropsychological testing * Geographic accessibility to the study site * Must have a study partner who can participate as required in the protocol (provide corroborative information) * Up to 12 years of education * Fits into one of the following groups: Cognitively Unimpaired, Subjective Cognitive Impairment, Mild Cognitive Impairment, Vascular Mild Cognitive Impairment, Parkinson's Disease, Parkinson's Disease with Mild Cognitive Impairment Exclusion Criteria: * The presence of other significant known chronic brain disease such as: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, malignant tumors, Parkinson's disease (other than for the Parkinson's cohort), and other rarer brain illnesses * Ongoing alcohol or drug abuse which in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures * Symptomatic stroke within the previous year * Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure

Primary outcome measure(s)

Trial sites (19)

FacilityCityRegionStatus
University of Calgary Calgary Alberta Recruiting
University of Alberta Hospital Edmonton Alberta Recruiting
Djavad Mowafaghian Centre for Brain Health Vancouver British Columbia Recruiting
Island Health Victoria British Columbia Not Yet Recruiting
Veteran's Memorial Building Halifax Nova Scotia Recruiting
Hamilton General Hospital Hamilton Ontario Recruiting
St. Joseph's Health Care London London Ontario Recruiting
Gait and Brain Lab London Ontario Recruiting
Bruyère Research Institute Ottawa Ontario Active Not Recruiting
Kawartha Centre Peterborough Ontario Active Not Recruiting
Sunnybrook Health Sciences Centre Toronto Ontario Active Not Recruiting
University Health Network Memory Clinic Toronto Ontario Active Not Recruiting
Baycrest Clinical Unit Toronto Ontario Recruiting
University of Waterloo Waterloo Ontario Active Not Recruiting
Research Institute of the McGill University Health Centre Montreal Quebec Active Not Recruiting
Jewish General Hospital/McGill Memory Clinic Montreal Quebec Recruiting
Clinique de cognition Institut universitaire de gériatrie de Montréal Montreal Quebec Recruiting
Hôpital Enfant-Jésus Québec Quebec Recruiting
Centre de recherche sur le vieillissement CIUSSS de l'Estrie-CHUS Sherbrooke Quebec Active Not Recruiting

More McGill University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03402919 on ClinicalTrials.gov ↗ ← All trials in Canada